See Spot live longer: Antiaging pill for dogs clears key FDA hurdle
The start-up Loyal developed a pill to extend dogs’ lifespan that has been recognized by the FDA as having “reasonable expectation of effectiveness.”
FDA delays when a final rule on what foods can be labeled as ‘healthy’ goes into effect
The US Food and Drug Administration’s new standards for foods before they can be labeled as “healthy” on their packaging will go into effect about two months later than planned, according to a government document scheduled to be published in the Federal Register on Tuesday.
Map Shows States With Listeria Cases as FDA Recalls Nutritional Shake
Listeria outbreak linked with supplemental shakes now stands at 12 deaths, FDA says
US FDA, CDC investigating multi-state listeria outbreak
'This guy': Trump Jr.’s hunting buddy to be top food regulator at FDA
What we are seeing from this administration is literally an inversion of a merit-based system—a spoils system for cronies and buddies of Trump and his kids,” says Chris Hayes.
FDA Asks 300 Fired Scientists to Return
The FDA plans to rehire around 300 people in total, according to four sources with secondhand knowledge of the situation, following President Donald Trump’s rush last week to fire employees at the agency responsible for reviewing drugs, food safety, medical devices and tobacco. Reuters could not verify the figure.
Ex-FDA commissioner on implications of agency’s ‘unreasonable’ jobs cuts
Dr. Robert Califf, former FDA commissioner and instructor at Duke Department of Medicine, explains the negative implications of over 700 jobs being cut from the agency under the Trump administration.

Drug compounders sue FDA over semaglutide status

Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list
Drug compounders sue over weight loss drugs’ removal from FDA shortage list
Drug compounders sue FDA over declaration ending Wegovy shortage
Smokescreen: some vape firms pivot after FDA crackdown
Such tactics have complicated U.S. efforts to stem the flow of vapes lacking authorisation into the country, according to the U.S. Food and Drug Administration (FDA)."The FDA is aware of, and closely monitoring,
BioSpace1h
Emalex Heads to FDA After Phase III Tourette Syndrome Win
In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with 68.1% of placebo comparators—resulting in a 50% relapse reduction, a statistically significant result, as per Emalex’s news release. These results remained true when analysis was expanded to cover both adults and children.